查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1928591

外骨骼增强设备市场按产品类型、移动性、动力源、应用和最终用户划分，全球预测，2026-2032年

Exoskeleton Enhancement Device Market by Product Type, Mobility, Power Source, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，外骨骼增强设备市场价值将达到 1.6592 亿美元，到 2026 年将成长至 1.9097 亿美元，到 2032 年将达到 4.5218 亿美元，复合年增长率为 15.39%。

关键市场统计数据
基准年 2025 1.6592亿美元
预计年份：2026年 1.9097亿美元
预测年份 2032 4.5218亿美元
复合年增长率 (%) 15.39%

外骨骼增强设备正迅速从专业原型阶段发展成为跨多个产业领域的应用型商业和机构解决方案。此技术架构整合了机械设计、驱动系统、控制演算法、感测器和人体工学，旨在创建能够辅助、增强或復健人类使用者的系统。轻量材料、电池能量密度和嵌入式电子技术的最新进展降低了其广泛应用的门槛，而人机介面的改进也增强了临床医生、工业安全团队和国防采购机构的信心。

随着讨论从概念验证阶段转向长期营运部署，可靠性、可维护性和用户体验日益受到关注。监管路径和标准与技术创新同步发展，要求相关人员在采购週期和政策限制之间权衡临床证据和现场绩效。在此背景下，本导言提供了一个清晰的框架，重点阐述了外骨骼增强设备如何与人体机能目标、安全要求以及新兴经营模式（例如设备即服务 (DaaS)、租赁安排和整合式护理通讯协定）相交织。本导言为后续关于市场驱动因素、风险、技术转折点和竞争动态的策略性讨论奠定了基础。

感测器融合、模组化架构、人体工学检验、不断演进的法规结构以及供应链韧性将如何重新定义采用路径

外骨骼增强设备的格局正受到多项变革性变化的影响，这些变化影响着设计重点、应用路径和价值提案。首先，感测器融合和自适应控制演算法正推动设备从预编程辅助转向情境察觉互动，从而实现更精细的增强和与用户意图的无缝衔接。其次，模组化的硬体和软体架构促进了互通性和快速迭代周期，使製造商能够自由组合驱动模组、控制堆迭和使用者介面，以满足各种不同的应用情境。

评估近期关税变化对供应链调整、本地生产、成本设计策略和采购韧性的影响

贸易政策发展，包括关税调整，对外骨骼设备生态系统的累积影响是多方面的，促使整个供应链采取策略性因应措施。关税带来的成本压力迫使製造商和整合商重新评估其关键零件（例如致动器、电力电子元件和感测器套件）的筹资策略。为此，一些公司正在实现供应商多元化，加快对替代供应商的资格认证，并探索区域製造，以降低跨境关税和物流限制的风险。

全面的細項分析揭示了应用、产品类型、最终用户、行动性和电源如何驱动不同的开发和商业化需求。

详细的細項分析揭示了不同应用、产品类型、最终用户、行动方式和动力来源所带来的技术优先顺序、监管考量和商业模式的差异。从应用主导的差异检验，辅助应用案例着重于物料搬运和移动辅助，旨在最大限度地提高专业用户的耐用性和安全性；而增强应用案例则优先考虑提高耐用性和增强力量，以满足需要重复用力或重物搬运的任务需求。復健应用案例着重于临床疗效，而物理治疗通讯协定和中风后復健路径等细分领域则需要已证实的治疗益处和以復健为中心的介面。

区域监管协调、生产规模扩大、国防优先事项和临床基础设施如何影响采用和部署策略

区域趋势塑造着需求征兆、製造策略、监管合规和伙伴关係模式，进而影响近期部署和长期能力建构。在美洲，采购活动往往受到工业安全计画和国防现代化努力的共同驱动，从而推动了现成产品改造和客製化系统整合相结合的混合模式。该地区的供应链受益于先进零件供应商、完善的临床研究基础设施以及支持职业健康和退伍军人復健计画临床试验的政策环境。

竞争格局分析表明，智慧财产权实力、临床伙伴关係、供应链安全和服务模式将决定市场领导地位的走向。

外骨骼增强设备领域的竞争格局由众多参与者所构成，包括成熟的工业OEM厂商、专业医疗设备製造商、新兴创新企业和国防承包商。主要企业融合多学科工程、临床研究伙伴关係和现场服务能力，以提供差异化价值。成功因素包括强大的智慧财产权、在实际运作环境中久经考验的可靠性，以及提供生命週期服务的能力，例如维护、软体更新和使用者培训计画。

为加速可扩展应用，提供协调工程、监管策略、供应链韧性和商业模式的实用建议

为了加速永续应用，产业领导者应采取整合产品工程、监管规划和商业部署的策略。首先，将以人性化的设计和长期磨损测试融入开发週期，确保设备满足实际使用需求并最大限度降低弃用风险。其次，积极推广模组化架构和组件标准化，以降低设备复杂性，促进售后支持，并创建延长产品生命週期的升级路径。

为确保研究结果的可靠性，我们采用了以下调查方法：结合一手访谈、技术实质审查、供应链分析和交叉检验情境分析。

我们的调查方法结合了定性和定量方法，旨在建立外骨骼增强设备的整体情况。主要研究包括对来自国防、工业和医疗领域的高级工程领导、采购负责人、临床医生和最终用户进行深度访谈，以深入了解营运限制、检验要求和采购决策标准。次要研究包括对学术文献、标准文件、专利申请和已发布的监管指南进行系统性回顾，检验技术趋势并绘製合规路径图。

结论是对人性化的测试、模组化设计、监管参与和强有力的商业策略进行综合考量，以产生持久的影响。

总之，外骨骼增强设备处于机械创新、人体工学以及不断变化的采购和法规环境的交汇点。感测、驱动和控制技术的进步正在开闢新的应用领域，而商业模式和供应链策略也在不断发展，以支援更广泛的部署。将严格的人性化的测试、模组化设计方法和监管参与纳入其蓝图的相关人员，将更有能力将原型转化为可持续的运作能力。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 外骨骼增强设备市场（依产品类型划分）

  • 活动类型
    • 电动主动式
    • 液压主动式
  • 被动的
    • 刚性被动式
    • 软被动式

9. 外骨骼增强设备市场依运动范围划分

  • 全身
  • 下肢
    • 踝
    • 髋关节
    • 膝盖
  • 上肢
    • 弯头
    • 肩膀
    • 手腕

第十章 外骨骼增强设备市场（依动力来源）

  • 电的
    • 电池供电
    • 有线型
  • 油压
    • 闭合电路
    • 开路
  • 气动
    • 压缩空气
    • 弹簧气压

第十一章 外骨骼增强设备市场（依应用领域划分）

  • 辅助的
    • 载重
    • 行动辅助
  • 功能增强
    • 耐力提升
    • 肌肉强化
  • 復原
    • 物理治疗
    • 中风后康復

第十二章 外骨骼增强设备市场（依最终用户划分）

  • 防御
    • 执法机关
    • 军队
  • 工业的
    • 后勤
    • 製造业
  • 医疗保健
    • 诊所
    • 居家照护
    • 医院

第十三章 外骨增强设备市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 外骨骼增强设备市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国外骨增强设备市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国外骨增强设备市场

第十七章 中国外骨增强设备市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • B-Temia Inc.
  • Bionik Laboratories Corp.
  • Comau SpA
  • CYBERDYNE Inc.
  • DIH Medical AG
  • Ekso Bionics Holdings, Inc.
  • Fourier Intelligence Pte. Ltd.
  • German Bionic Systems GmbH
  • Hyundai Motor Group Robotics LAB
  • Levitate Technologies, Inc.
  • Lifeward, Inc.
  • Lockheed Martin Corporation
  • Myomo, Inc.
  • Ottobock SE & Co. KGaA
  • Parker-Hannifin Corporation
  • ReWalk Robotics Ltd.
  • Rex Bionics Ltd.
  • Sarcos Technology and Robotics Corporation
  • Wandercraft SA
Product Code: MRR-92740D85F053

The Exoskeleton Enhancement Device Market was valued at USD 165.92 million in 2025 and is projected to grow to USD 190.97 million in 2026, with a CAGR of 15.39%, reaching USD 452.18 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 165.92 million
Estimated Year [2026] USD 190.97 million
Forecast Year [2032] USD 452.18 million
CAGR (%) 15.39%

Exoskeleton enhancement devices are rapidly moving from specialized prototypes into applied commercial and institutional solutions across multiple industries. The technology architecture integrates mechanical design, actuation systems, control algorithms, sensors, and human factors engineering to produce systems that either assist, augment, or rehabilitate human users. Recent advances in lightweight materials, battery energy density, and embedded electronics have reduced barriers to wider adoption, while improvements in human-machine interfaces have raised confidence among clinicians, industrial safety teams, and defense procurement bodies.

As the discourse shifts from proof-of-concept demonstrations to long-term operational deployments, attention is increasingly focused on reliability, maintainability, and the user experience. Regulatory pathways and standards are evolving in parallel with technical innovation, and so stakeholders must balance clinical evidence and field performance with procurement cycles and policy constraints. In this context, a clear introductory framing emphasizes how exoskeleton enhancement devices intersect with human performance objectives, safety imperatives, and emerging business models such as device-as-a-service, lease arrangements, and integrated care protocols. This introduction establishes the baseline for a strategic examination of market drivers, risks, technological inflection points, and competitive dynamics that follow.

How sensor fusion, modular architectures, ergonomic validation, evolving regulatory frameworks, and supply chain resilience are redefining adoption pathways

The landscape for exoskeleton enhancement devices is being reshaped by several transformative shifts that affect design priorities, adoption pathways, and value propositions. First, sensor fusion and adaptive control algorithms have enabled devices to transition from pre-programmed assistance to context-aware interaction, permitting finer-tuned augmentation and smoother integration with user intent. Second, modular hardware and software architectures are fostering interoperability and faster iteration cycles, permitting manufacturers to mix-and-match actuation modules, control stacks, and user interfaces to address diverse use cases.

Concurrently, the growing emphasis on ergonomic validation and long-duration wearability has redirected engineering effort toward energy-efficient actuation and improved human factors. Regulatory frameworks and standards initiatives are advancing, creating clearer routes for medical device approvals and occupational safety certifications. At the same time, commercial models are diversifying: finance structures that reduce capital expenditure barriers are enabling broader uptake in industrial and clinical settings. Finally, supply chain resilience and nearshoring strategies are influencing component sourcing and manufacturing footprints, prompting original equipment manufacturers and suppliers to reconsider risk, lead times, and localized support capabilities. These shifts collectively accelerate the transition from niche deployments to scaled, sustainable implementations across defense, industrial, and medical environments.

Assessing how recent tariff shifts have driven supply chain adjustments, localized manufacturing, design-for-cost strategies, and procurement resilience

The cumulative impact of trade policy developments, including tariff adjustments, on the exoskeleton device ecosystem is multifaceted and has prompted strategic responses across supply chains. Tariff-induced cost pressures have encouraged manufacturers and integrators to re-evaluate sourcing strategies for critical components such as actuators, power electronics, and sensor suites. In response, several players have diversified suppliers, accelerated qualification of alternative vendors, and explored regional manufacturing to mitigate exposure to cross-border duties and logistical constraints.

Beyond direct cost implications, tariffs have influenced partnership models and procurement decisions. System integrators and buyers are increasingly prioritizing local content and supply-chain traceability to reduce vulnerability to policy volatility. This has translated into deeper collaboration between engineering, procurement, and legal teams to embed trade compliance and tariff mitigation into product roadmaps. Furthermore, price sensitivity driven by tariffs has intensified focus on design-for-cost and component standardization, prompting product teams to identify opportunities to streamline bill of materials and adopt common subassemblies. Finally, organizations that align their sourcing and manufacturing footprint with anticipated policy trends are better positioned to maintain competitive pricing while sustaining investment in R&D and post-sale support.

Comprehensive segmentation insights exposing how application, product type, end user, mobility, and power source drive distinct development and commercialization imperatives

A granular segmentation view reveals distinct engineering priorities, regulatory considerations, and commercial models that vary by application, product type, end user, mobility, and power source. When examining application-led distinctions, assistance use cases emphasize load carriage and mobility assistance that maximize endurance and safety for occupational users, whereas augmentation applications prioritize endurance enhancement and strength amplification for tasks requiring repetitive exertion or heavy lifting. Rehabilitation applications focus on clinical efficacy, with sub-specializations in physical therapy protocols and post-stroke recovery paths that require proven therapeutic outcomes and rehabilitation-centric interfaces.

Product type segmentation differentiates active systems that rely on electric or hydraulic actuation from passive systems that use rigid or soft structures to redistribute loads or stabilize motion. Active devices necessitate control electronics, power management, and serviceable actuation, while passive devices emphasize material science, elastic elements, and simplicity of use. End user segmentation exposes divergent procurement cycles and validation needs across defense customers, industrial operators, and medical institutions; law enforcement and military applications demand ruggedization and mission-tailored capabilities, logistics and manufacturing environments prioritize cycle time and worker comfort, and clinics, home care, and hospitals require clinical validation, seamless integration into care pathways, and reimbursement considerations.

Mobility-focused segmentation-full body, lower limb, and upper limb-drives design trade-offs between range-of-motion, weight distribution, and control complexity. Lower limb devices address ankle, hip, and knee augmentation or support with individualized gait analytics, while upper limb devices attend to elbow, shoulder, and wrist assistance that demand fine-grained dexterity and haptic compatibility. Power source segmentation separates electric, hydraulic, and pneumatic approaches; electric systems differentiate between battery-powered and wired options, hydraulics are evaluated on closed-circuit versus open-circuit architectures, and pneumatic solutions use either compressed air or spring-assisted pneumatic designs. Integrating these segmentation lenses offers a composite understanding of how product architecture, regulatory hurdles, and end-user requirements coalesce to shape development roadmaps and commercialization strategies.

How regional regulatory harmonization, manufacturing scale-up, defense priorities, and clinical infrastructure are shaping adoption and deployment strategies

Regional dynamics shape demand signals, manufacturing strategies, regulatory compliance, and partnership models in ways that influence both near-term deployments and long-term capability building. In the Americas, procurement tends to be driven by a combination of industrial safety programs and defense modernization efforts, which encourages a hybrid of commercial off-the-shelf adaptations and bespoke system integration. Regional supply chains there benefit from access to advanced component suppliers, established clinical research infrastructure, and a policy environment that supports trials in occupational health and veterans' rehabilitation programs.

In Europe, Middle East & Africa, regulatory harmonization across several markets is pushing vendors to streamline certification strategies and invest in multi-jurisdictional clinical evidence generation. The region's strong industrial manufacturing base and a growing focus on worker wellbeing have catalyzed pilot programs in manufacturing and logistics hubs, while defense and humanitarian applications in certain markets are shaping bespoke requirements. Meanwhile, the Asia-Pacific region is characterized by rapid manufacturing scale-up, a large pool of engineering talent, and diverse adoption rates that range from early-stage clinical pilots to aggressive industrial rollouts. Local incentives for advanced manufacturing, coupled with expanding private investment into robotics and wearable technologies, are accelerating capabilities, while regional variance in standards and procurement cycles requires flexible market-entry approaches. Across these regions, aligning product development with local regulatory and procurement realities is critical to unlocking sustainable adoption and operational support networks.

Competitive landscape analysis showing how IP strength, clinical partnerships, supply chain security, and service models determine market leadership trajectories

Competitive dynamics in the exoskeleton enhancement device space are defined by diverse players spanning established industrial OEMs, specialized medical device manufacturers, startup innovators, and defense contractors. Leading organizations combine multidisciplinary engineering, clinical research partnerships, and field-service capabilities to deliver differentiated value. Success factors include a robust intellectual property position, demonstrated reliability in operational settings, and the capacity to provide lifecycle services such as maintenance, software updates, and user training programs.

Collaboration patterns are increasingly influential: alliances between actuation suppliers, sensor developers, and systems integrators enable more rapid product maturity while shared validation frameworks reduce time-to-acceptance with end users. Strategic partnerships with rehabilitation clinics, academic centers, and occupational health programs also support evidence generation and adoption. Supply chain relationships matter equally; companies that secure low-risk sources for high-value components and that maintain transparent logistics networks gain a competitive edge. Finally, commercialization strategies that combine direct sales, channel partnerships, and service-based offerings provide flexibility to address the heterogenous needs of defense, industrial, and medical customers, allowing firms to scale in a staged manner while managing revenue predictability and customer retention.

Actionable recommendations for synchronizing engineering, regulatory strategy, supply chain resilience, and commercial models to accelerate scalable adoption

Industry leaders should adopt an integrated strategy that synchronizes product engineering, regulatory planning, and commercial deployment to accelerate sustainable adoption. First, embed human-centered design and long-duration wear testing into development cycles to ensure devices meet real-world operational demands and to minimize abandonment risk. Second, proactively pursue modular architectures and component standardization to lower unit complexity, facilitate aftermarket support, and create upgrade pathways that extend product lifecycles.

Third, align regulatory and clinical evidence plans with targeted end-user pathways by engaging early with occupational safety authorities, clinical partners, and procurement agencies to co-develop validation studies and use-case documentation. Fourth, strengthen supply chain resilience through dual-sourcing strategies, qualification of regional suppliers, and selective nearshoring for critical components to mitigate policy and logistics shocks. Fifth, develop flexible commercial frameworks-ranging from outright sales to as-a-service models-to lower customer adoption barriers and to capture recurring revenue streams; complement these with training, certification, and field-support offerings to drive retention. Lastly, invest in data analytics capabilities and secure connectivity frameworks to capture usage metrics that inform continuous improvement, support reimbursement discussions in medical contexts, and demonstrate operational ROI to industrial and defense buyers. This combination of technical rigor, regulatory alignment, and commercial flexibility positions leaders to convert innovation into scalable, mission-aligned deployments.

Methodology combining primary interviews, technical due diligence, supply chain mapping, and cross-validated scenario analysis to ensure robust insights

The research methodology combined qualitative and quantitative approaches to build a holistic picture of the exoskeleton enhancement device landscape. Primary research included in-depth interviews with senior engineering leads, procurement officers, clinical practitioners, and end users across defense, industrial, and medical settings, which informed insights into operational constraints, validation requirements, and procurement decision criteria. Secondary research entailed a structured review of academic literature, standards documents, patent filings, and publicly available regulatory guidance to validate technology trajectories and to map compliance pathways.

Technical due diligence was conducted through device specification analysis and component benchmarking, emphasizing actuation options, control architectures, and power systems. Supply chain analysis assessed vendor concentration, lead-time variability, and logistics risk to understand sourcing vulnerabilities. Scenario analysis explored policy and procurement permutations and their operational implications. Finally, cross-validation workshops with independent subject-matter experts refined findings and identified methodological limitations. Where data gaps existed, triangulation across multiple sources and conservative framing were applied to preserve analytical integrity. This layered methodology ensured that conclusions reflect a balanced synthesis of practitioner experience, technical validation, and policy context.

Concluding synthesis emphasizing human-centered testing, modular design, regulatory engagement, and resilient commercial strategies for sustained impact

In closing, exoskeleton enhancement devices sit at the intersection of mechanical innovation, human factors engineering, and evolving procurement and regulatory environments. Technological advances in sensing, actuation, and control are unlocking new application horizons, while commercial models and supply chain strategies are evolving to support broader deployment. Stakeholders who integrate rigorous human-centered testing, modular design approaches, and regulatory engagement into their roadmaps will be better poised to translate prototypes into sustained operational capability.

Looking ahead, success will depend less on isolated technological breakthroughs and more on the coherent orchestration of design, evidence generation, and delivery models that address the diverse needs of defense, industrial, and medical users. Organizations that adopt resilient sourcing strategies and flexible commercial offerings will be more capable of navigating policy shifts and varied regional requirements. Ultimately, the maturity of the ecosystem will be determined by demonstrable improvements in safety, productivity, and clinical outcomes that justify investment and foster long-term adoption across sectors.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Exoskeleton Enhancement Device Market, by Product Type

  • 8.1. Active
    • 8.1.1. Electric Active
    • 8.1.2. Hydraulic Active
  • 8.2. Passive
    • 8.2.1. Rigid Passive
    • 8.2.2. Soft Passive

9. Exoskeleton Enhancement Device Market, by Mobility

  • 9.1. Full Body
  • 9.2. Lower Limb
    • 9.2.1. Ankle
    • 9.2.2. Hip
    • 9.2.3. Knee
  • 9.3. Upper Limb
    • 9.3.1. Elbow
    • 9.3.2. Shoulder
    • 9.3.3. Wrist

10. Exoskeleton Enhancement Device Market, by Power Source

  • 10.1. Electric
    • 10.1.1. Battery Powered
    • 10.1.2. Wired
  • 10.2. Hydraulic
    • 10.2.1. Closed Circuit
    • 10.2.2. Open Circuit
  • 10.3. Pneumatic
    • 10.3.1. Compressed Air
    • 10.3.2. Spring Pneumatic

11. Exoskeleton Enhancement Device Market, by Application

  • 11.1. Assistance
    • 11.1.1. Load Carriage
    • 11.1.2. Mobility Assistance
  • 11.2. Augmentation
    • 11.2.1. Endurance Enhancement
    • 11.2.2. Strength Enhancement
  • 11.3. Rehabilitation
    • 11.3.1. Physical Therapy
    • 11.3.2. Post-Stroke Recovery

12. Exoskeleton Enhancement Device Market, by End User

  • 12.1. Defense
    • 12.1.1. Law Enforcement
    • 12.1.2. Military
  • 12.2. Industrial
    • 12.2.1. Logistics
    • 12.2.2. Manufacturing
  • 12.3. Medical
    • 12.3.1. Clinic
    • 12.3.2. Home Care
    • 12.3.3. Hospital

13. Exoskeleton Enhancement Device Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Exoskeleton Enhancement Device Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Exoskeleton Enhancement Device Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Exoskeleton Enhancement Device Market

17. China Exoskeleton Enhancement Device Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. B-Temia Inc.
  • 18.6. Bionik Laboratories Corp.
  • 18.7. Comau S.p.A.
  • 18.8. CYBERDYNE Inc.
  • 18.9. DIH Medical AG
  • 18.10. Ekso Bionics Holdings, Inc.
  • 18.11. Fourier Intelligence Pte. Ltd.
  • 18.12. German Bionic Systems GmbH
  • 18.13. Hyundai Motor Group Robotics LAB
  • 18.14. Levitate Technologies, Inc.
  • 18.15. Lifeward, Inc.
  • 18.16. Lockheed Martin Corporation
  • 18.17. Myomo, Inc.
  • 18.18. Ottobock SE & Co. KGaA
  • 18.19. Parker-Hannifin Corporation
  • 18.20. ReWalk Robotics Ltd.
  • 18.21. Rex Bionics Ltd.
  • 18.22. Sarcos Technology and Robotics Corporation
  • 18.23. Wandercraft S.A.

LIST OF FIGURES

  • FIGURE 1. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MOBILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY POWER SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ACTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ACTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ACTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ELECTRIC ACTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ELECTRIC ACTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ELECTRIC ACTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY HYDRAULIC ACTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY HYDRAULIC ACTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY HYDRAULIC ACTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PASSIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PASSIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PASSIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY RIGID PASSIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY RIGID PASSIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY RIGID PASSIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY SOFT PASSIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY SOFT PASSIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY SOFT PASSIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY FULL BODY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY FULL BODY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY FULL BODY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY LOWER LIMB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY LOWER LIMB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ANKLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ANKLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ANKLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY HIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY HIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY HIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY KNEE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY KNEE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY KNEE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY UPPER LIMB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY UPPER LIMB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY UPPER LIMB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ELBOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ELBOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ELBOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY SHOULDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY SHOULDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY SHOULDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY WRIST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY WRIST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY WRIST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ELECTRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ELECTRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ELECTRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ELECTRIC, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY BATTERY POWERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY BATTERY POWERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY BATTERY POWERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY WIRED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY WIRED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY WIRED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY HYDRAULIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY HYDRAULIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY HYDRAULIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY HYDRAULIC, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY CLOSED CIRCUIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY CLOSED CIRCUIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY CLOSED CIRCUIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY OPEN CIRCUIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY OPEN CIRCUIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY OPEN CIRCUIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PNEUMATIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PNEUMATIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PNEUMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PNEUMATIC, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY COMPRESSED AIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY COMPRESSED AIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY COMPRESSED AIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY SPRING PNEUMATIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY SPRING PNEUMATIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY SPRING PNEUMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ASSISTANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ASSISTANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ASSISTANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY LOAD CARRIAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY LOAD CARRIAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY LOAD CARRIAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MOBILITY ASSISTANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MOBILITY ASSISTANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MOBILITY ASSISTANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY AUGMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY AUGMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY AUGMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY AUGMENTATION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ENDURANCE ENHANCEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ENDURANCE ENHANCEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ENDURANCE ENHANCEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY STRENGTH ENHANCEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY STRENGTH ENHANCEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY STRENGTH ENHANCEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PHYSICAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PHYSICAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY POST-STROKE RECOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY POST-STROKE RECOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY POST-STROKE RECOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY DEFENSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY DEFENSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY DEFENSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY LAW ENFORCEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY LAW ENFORCEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY LAW ENFORCEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MILITARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MILITARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MILITARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY INDUSTRIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY INDUSTRIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY LOGISTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY LOGISTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY LOGISTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MEDICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MEDICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MEDICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 155. AMERICAS EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 156. AMERICAS EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 158. AMERICAS EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ELECTRIC, 2018-2032 (USD MILLION)
  • TABLE 159. AMERICAS EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY HYDRAULIC, 2018-2032 (USD MILLION)
  • TABLE 160. AMERICAS EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PNEUMATIC, 2018-2032 (USD MILLION)
  • TABLE 161. AMERICAS EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. AMERICAS EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY AUGMENTATION, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. AMERICAS EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 168. AMERICAS EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ELECTRIC, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY HYDRAULIC, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PNEUMATIC, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY AUGMENTATION, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ELECTRIC, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY HYDRAULIC, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PNEUMATIC, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY AUGMENTATION, 2018-2032 (USD MILLION)
  • TABLE 202. LATIN AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. LATIN AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 206. LATIN AMERICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ELECTRIC, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY HYDRAULIC, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PNEUMATIC, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY AUGMENTATION, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ELECTRIC, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY HYDRAULIC, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PNEUMATIC, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY AUGMENTATION, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. MIDDLE EAST EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 248. MIDDLE EAST EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 250. MIDDLE EAST EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 252. MIDDLE EAST EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ELECTRIC, 2018-2032 (USD MILLION)
  • TABLE 254. MIDDLE EAST EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY HYDRAULIC, 2018-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PNEUMATIC, 2018-2032 (USD MILLION)
  • TABLE 256. MIDDLE EAST EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 258. MIDDLE EAST EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY AUGMENTATION, 2018-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 260. MIDDLE EAST EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 262. MIDDLE EAST EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 264. AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 267. AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 268. AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 269. AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 270. AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 271. AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 272. AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ELECTRIC, 2018-2032 (USD MILLION)
  • TABLE 273. AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY HYDRAULIC, 2018-2032 (USD MILLION)
  • TABLE 274. AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PNEUMATIC, 2018-2032 (USD MILLION)
  • TABLE 275. AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 277. AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY AUGMENTATION, 2018-2032 (USD MILLION)
  • TABLE 278. AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 279. AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 281. AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 282. AFRICA EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ACTIVE, 2018-2032 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PASSIVE, 2018-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ELECTRIC, 2018-2032 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY HYDRAULIC, 2018-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY PNEUMATIC, 2018-2032 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 296. ASIA-PACIFIC EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY AUGMENTATION, 2018-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 299. ASIA-PACIFIC EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 300. ASIA-PACIFIC EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY INDUSTRIAL, 2018-2032 (USD MILLION)
  • TABLE 301. ASIA-PACIFIC EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY MEDICAL, 2018-2032 (USD MILLION)
  • TABLE 302. GLOBAL EXOSKELETON ENHANCEMENT DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 303. ASEAN EXOSKELETON ENHANCEMENT DEV